logo

For the Inventor, By the Inventor

San Jose, CA, United States of America

Teikoku Pharma Usa, Inc.


USPTO Granted Patents = 51



Trademarks = 9

Forward Citations = 190

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Jutaro Shudo (15 out of 15 patents)

silverMedal Jianye Wen (13 out of 19 patents)

bronzeMedal Carter R Anderson (12 out of 31 patents)

4.  Russell L Morris (9 out of 27 patents)

5.  Amit K Jain (8 out of 27 patents)

6.  Kiichiro Nabeta (8 out of 9 patents)

7.  Bret Berner (7 out of 65 patents)

8.  Adchara Pongpeerapat (7 out of 8 patents)

9.  Richard D Hamlin (7 out of 9 patents)

10.  Kensuke Murata (5 out of 5 patents)

11.  William V Fowler (4 out of 15 patents)

12.  Sadanobu Shirai (3 out of 9 patents)

13.  Robert Cohen (3 out of 6 patents)

14.  John Koo (3 out of 3 patents)

15.  Toru Hibi (3 out of 3 patents)


Core Competencies:
Transdermal Delivery
Dexmedetomidine
Sphingosine-1-Phosphate
Rivastigmine
Taxane Formulations
Narcotic Emulsions
Dermatological Agents
Iontophoresis
Pain Relief Patches
Medication Disposal
Hormonal Delivery
Abuse Potential Reduction

51 patents:

1. 12364692 - Topical naloxone compositions and methods for using the same (2025-07-22),
2. 10987342 - Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine (2021-04-27),
3. 10918607 - Propynylaminoindan transdermal compositions (2021-02-16),
4. 10874642 - Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions (2020-12-29),
5. 10842770 - Non-aqueous taxane pro-emulsion formulations and methods of making and using the same (2020-11-24),
6. 10772871 - Dexmedetomidine transdermal delivery devices and methods for using the same (2020-09-15),
7. 10617655 - Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same (2020-04-14),
8. 10357463 - Rivastigmine transdermal compositions and methods of using the same (2019-07-23),
9. 10188616 - Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same (2019-01-29),
10. 10022340 - Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same (2018-07-17),
11. 9949935 - Rivastigmine transdermal compositions and methods of using the same (2018-04-24),
12. 9913812 - Methods for the treatment of skin neoplasms (2018-03-13),
13. 9827207 - Propynylaminoindan transdermal compositions (2017-11-28),
14. 9763880 - Non-aqueous taxane formulations and methods of using the same (2017-09-19),
15. 9597301 - Propynylaminoindan transdermal compositions (2017-03-21),
Teikoku Pharma USA, Inc. is a leading pharmaceutical company focused on developing innovative drug delivery systems. We specialize in the research, development, and commercialization of advanced pharmaceutical products. Committed to improving patient outcomes, we work closely with healthcare professionals and partners to bring novel therapies to market. Visit our website for more information.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

51 Patents

#171 in San Jose, CA

#1,580 in California

#6,661 in US

#13,382 in the World

...
San Jose, CA, United States of America

Teikoku Pharma Usa, Inc.

Forward Citations = 190

32 inventors:

goldMedal Jutaro Shudo (15 out of 15 patents)

silverMedal Jianye Wen (13 out of 19 patents)

bronzeMedal Carter R Anderson (12 out of 31 patents)

4.  Russell L Morris (9 out of 27 patents)

5.  Amit K Jain (8 out of 27 patents)

Please report any incorrect information to support@idiyas.com
Loading…